PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES  by Shah, A.J. et al.
aspect, evaluation criteria and schemes of HTA system. Based on analytic hierarch
process (AHP) methods, Wemake interviews with health officials, health care pro-
viders and customers by using the AHP questionnaire. Fuzzy multiple criteria de-
cision making (Fuzzy MCDM) was adopted to proceed the empirical evidence anal-
ysis and evaluation on the schemes of HTA systems. RESULTS: A total of 65
participants were included in this survey. Three category’s aspect, twelve evalua-
tion criteria and three schemes of HTA system were generated. For the category’s
aspect, the sequence of importance is ‘To meet the expectations of health care
providers’, then ‘To satisfy the requirements of customer’ and the last is ‘To ac-
complish the coverage policy of government’ (0.375, 0.337 and 0.238, respectively).
The deviation of balancing weight among these three aspects is little and the
importance is very similar. The effective score of HTA systems, which is evaluated
and selected by whole interviewers, the sequence from large to small is ‘system of
safety and efficacy’, ‘system of ethical standards’, and ‘system of cost effective-
ness’ (67.18, 61.41 and 58.01, respectively). CONCLUSIONS: The ‘system of cost
effectiveness’ is not suitable to adopt at current stage. It does not meet the expec-
tations from health care stakeholders if there is only one HTA system. The Bureau
of National Health Insurance should select ‘system of safety and efficacy’ as the
basis to establish a new, proper HTA system in Taiwan.
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OBJECTIVES: Antimicrobial resistance (AMR) is a global public health problem.
Antibiotic misuse is one of the important factors for increasing trend of AMR. In
developing countries like India, pharmacists often dispense “prescription only”
drugs, like antibiotics to patients who do not have a prescription. It is important to
understand the dispensing practices and behaviour of community pharmacists in
order to develop policy interventions that will effectively improve the use of anti-
biotics at the community level. METHODS: Focus group discussions (FGDs) were
held for five municipal wards of Delhi with retail pharmacists, public sector phar-
macists and the office-bearers of pharmacists’ associations. Data on antibiotic use
and resistance was collected earlier in these five wards. FGDs (n3 with 40 phar-
macists) were analysed through grounded theory. RESULTS: From the FGDs four
broad themes identified were: prescribing and dispensing behaviour; commercial
interests; advisory role; and intervention strategies for rational use of antibiotics
whichwere further divided into sub themes. FGDswith pharmacistsworking in the
public sector found that, besides the factors listed above, overstock and near-
expiry, and under supply of antibiotics, promoted antibiotic over-use or under-use.
Findings elucidates pharmacists’ role in increasing AMR through inappropriate
dispensing practices and profit-driven irrational prescribing. Suggestions for inter-
ventions from pharmacists were (1) education to increase awareness about ratio-
nal use and resistance to antibiotics for pharmacists; (2) involving themas partners
to create awareness among communities for rational use and resistance to antibi-
otics; and (3) developing an easy return policy for near-expiry antibiotics in public
sector facilities. CONCLUSIONS: In a scenario where pharmacists are not only
intermediates between prescribers and users, but are also prescribing and dispens-
ing, they become important stakeholders for intervention programs. A multidisci-
plinary team of policymakers should design sustainable intervention programs to
improve pharmacists’ antibiotic prescribing behavior, as well as awareness pro-
grams for community members.
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OBJECTIVES: Prescription drug monitoring programs (PDMPs) have been imple-
mented by states as a means to reduce abuse and diversion of controlled sub-
stances (CS). Relatively little is known, however, about their effectiveness in
achieving these goals. The purpose of this project was to assess the perceived
impact of the Kentucky All Schedule Prescription Electronic Reporting program
(KASPER) on CS prescribing behavior and to evaluate the perceived effectiveness of
KASPER as a tool to reduce drug abuse, diversion and doctor shopping.METHODS:
A sample of two thousand prescribers, including physicians, advanced practice
nurses and dentists, was randomly selected from a list of over 4,000 registeredwith
KASPER. The prescribers were contacted viamail to complete a survey. A reminder
postcard and second survey was sent to non-responders two weeks after the first
mailing. Five hundred fifty-seven (557) responses were received from prescribers
for a response rate of approximately 28%. Responses were coded and descriptive
analysis was conducted in STATA v11. RESULTS: The majority (89%) of prescribers
responding to the survey were physicians who reported using a mean of 19.7
KASPER reports monthly for treatment decisions. 89% of respondents indicated
that information in the reports impacts their treatment decisions. One-half of
respondents indicated no change in CS prescribing behavior over the past year as a
result of KASPER while 35% indicated a decrease in CS prescribing and 13% indi-
cated an increase in CS prescribing. 96% of respondents believe KASPER is an ef-
fective tool for reducing abuse and diversionwhile 95% believe it is an effective tool
to reduce doctor shopping.CONCLUSIONS:Respondents that use KASPER regularly
find the information in reports valuable for making treatment decisions. Overall,
the vast majority of respondents perceive KASPER as an effective tool to reduce
drug abuse, diversion and doctor shopping. Further research is needed to directly
assess the effectiveness of PDMPs.
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Hospital doctors influence general practitioners’ prescribing patterns. But, no
study has focused on the influence of hospital choices of drugs on prescribing
patterns in the community for competitive pharmacological classes at the macro
level. OBJECTIVES: To investigate the influence of hospital choices of drugs on the
pharmaceutical consumption in its surrounding community. METHODS: Quasi-
experimental study. Data from the national survey about drugs in hospitals of the
French Department of Health were used to extract purchased quantities in 2008 by
25 of the 29 French university hospitals for proton pump inhibitors (PPI), serotonin
antagonists (setrons), low molecular weight heparins (LMWH), erythropoietins
(EPO), angiotensin conversion enzyme inhibitors (ACEI), angiotensin II receptors
antagonists (ARA), statins, alpha-adrenoreceptor antagonists (AAA) and selective
serotonin reuptake inhibitors (SSRI). Reimbursed quantities from general practitio-
ners’ prescriptions for patients living in the hospital’s catchment area were ex-
tracted from the national health insurance database (concerning 90% of the popu-
lation). Quantities for each brand and each drug entity were expressed in defined
daily doses per 1000 hospitalizations-day (DHD) or 1000 inhabitants-day (DID) and
log-transformed. Correlations between consumption in university hospitals and
their catchment areaswere assessed using Spearman rank correlation coefficients.
RESULTS: University hospitals selected between 30 and 52% of the available drug
entities for these 9 classes. A correlation coefficient superior to 0.20 was calculated
for 45% of brand names and 75% of the drug entities. Significant correlations were
found for the classes of SSRI and ACEI. For statins, ARA, LMWH and setrons, cor-
relation was quite good but did not achieve statistical significance boundary. For
the remaining classes (PPI, EPO and AAA), correlation varied with the drugs, but
was globally nonexistent. CONCLUSIONS: Correlations between hospital and com-
munity uses varied with classes and drugs. The direction of the relationship, as
well as its determinants, will be further assessed in a multivariate analysis.
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OBJECTIVES:Guidance on public health topics such as contraception, smoking and
obesity is regularly provided in developed countries. These guidelines on social
behaviour have a tendency to be less distinct than those for explicit clinical con-
ditions, as they often recommend interventions such as support and access to
information rather than specific drugs or surgical procedures. The aimof this study
was to compare the implementation of behavioural guidance to that of guidance
recommending clinical interventions in various public health topics. METHODS:
All reports on the implementation of public health guidance in the UK that were
listed in July 2010 by theNational Institute for Health and Clinical Excellence (NICE)
were reviewed and compared. RESULTS: Six reports were published on the imple-
mentation of public health guidance. These focused on attention deficit hyperac-
tivity disorder, anxiety, long-acting reversible contraception, secondary preven-
tion of myocardial infarctions, obesity and smoking cessation. Implementation
was measured by either the Prescription Cost Analysis system, the electronic Pre-
scribing Analysis Cost Tool or through analysis of anonymised patient records.
Generally, guidance for clinical recommendations, such as drugs or surgical pro-
cedures, was accurately adhered to in the topics assessed. Conversely, supportive
recommendations, such as access to information and counselling, displayed very
limited implementation. However, these variables were very difficult to assess
through the current information systems available. CONCLUSIONS: For public
health guidance, it is often difficult to follow up on how well the advice is imple-
mented throughout society due to methodological difficulties in measuring sup-
portive interventions. However, there appears to be a clear trend towards the poor
implementation of behavioural guidance compared to specific recommendations
for drugs and surgical procedures. In public health topics, where guidance is often
indistinct, it is important that supportive recommendations are emphasised
enough for them to be implemented alongside clinical interventions.
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OBJECTIVES: TheUS Food andDrug Administration (FDA) has classified drugs used
in pregnancy into five categories namely A, B, C, D and X with category A being the
safest and category X being absolutely contraindicated in pregnancy based on fetal
risk associated with these medications. The objective of the study was to deter-
mine the time trend and predictors of FDA’s category D and X drugs among outpa-
tient visits in pregnant women.METHODS:A retrospective study using the 1997-98
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and 2005-06 National Ambulatory Medical Care Survey and the outpatient depart-
ment component of the National Hospital Ambulatory Medical Care Survey was
conducted to examine maternal characteristics and physician characteristics as-
sociated with Category D and X prescriptions. Descriptive statistics and logistic
regression analysis were performed to determine the time trend and predictors
associated with prescribing category D and X drugs. RESULTS: Approximately 35
million visits weremade by pregnantwomen annually during these years. Of these
visits, 1.4% (95%Confidence Interval (CI):1.13-1.77%) of the visits involved prescrip-
tion of Category D drugs and 1.1% (CI:0.6-1.4%) of the visits involved prescription of
Category X drugs. A significant positive time trend was observed in prescribing of
category D and X drugs in 2005-06 (OR-2.14, 95%CI:1.23-3.73) compared to 1997-98.
Pregnant women above the age of 30 had greater odds (OR-1.62, 95%CI:1.08-2.44) of
receiving these drugs than pregnant women below the age of 30. Pregnant women
who received 2 medications had greater odds (OR-15.31,95%CI:9.02-26.01) of re-
ceiving these drugs than who received 1 medication. Significant differences
across physician specialty and race were also observed. CONCLUSIONS: Both ma-
ternal and physician characteristics play a role in prescribing of Category D and X
drugs. With increase in use of category D and X drugs, more research is needed to
evaluate the clinical consequences of these prescribing practices.
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OBJECTIVES: To determine the association between quality of hospital care, using
selected Assessing Care of Vulnerable Elders (ACOVE) quality indicators, and short
term outcomes for very old patients admitted for acute illnesses in a tertiary
hospital.METHODS: This is a retrospective review of medical records of a random
sample of all patients aged 80 years and above admitted to the Department of
General Medicine and Department of Geriatric Medicine from 2005 to 2008, with an
equal number of cases (750) selected for each year. The quality indicators selected
were cognitive and functional assessment, discharge planning, delirium evalua-
tion and treatment, mobilization, and aspiration precautions. If patients met the
inclusion criteria for each specific quality indicator, they were assessed to deter-
mine if the process-of-care was carried out and documented. The outcomes of
interest were inhospital mortality, 30-day mortality and hospital readmission
within 15 days of discharge. RESULTS: From the review of 2,923 cases, the adher-
ence for the quality indicators ranged from 33.8% for cognitive and functional
assessment to 88.1% for discharge planning. In univariate analyses, adherence to
delirium evaluation and treatment was associated with a reduction in inhospital
(17.5% vs 26.1%, p0.004) and 30-day mortality rates (22.6% vs 32.5%, p0.002).
Documentation of cognitive and functional assessment was associated with a re-
duction in inhospital (6.2% vs 16.2%, p0.005) and 30-day mortality rates (10.3% vs
22.3%, p0.005). The association between adherence to quality indicators and hos-
pital readmission was not statistically significant. After adjustments using the
biovariate probit regression, adherence to aspiration precautions was associated
with lower inhospital mortality (rho-0.128 (95% Confidence Interval:
0.233,-0.021). CONCLUSIONS: Adherence to selected process-of-care quality in-
dicatorswas generally low. Adherence to aspiration precautionswas the only qual-
ity indicator that had an impact on the short term outcome for elderly patients
hospitalized for acute medical conditions.
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OBJECTIVES: CIGNA’s CoachRx pharmacymanagement programprovides services
to pharmacy customers with medication adherence and/or medication safety is-
sues/concerns. In this study, telephonic engagement with a CoachRx pharmacist
initiated the process. The aim of this analysis was to evaluate the effect of the
CoachRx program onmedication adherence; use of mail-order pharmacy services;
utilization of generic, preferred, and non-preferred-brand medications; and ingre-
dient costs. METHODS: A pre/post comparison spanning one year (6mo pre/6mo
post) was conducted. Adherence was measured at the customer level. Continu-
ously enrolled individuals were identified, and the following demographic infor-
mation was collected: age, sex, and employer. Medication possession ratio was
used to measure adherence for five classes of medications: asthma, depression,
diabetes, dyslipidemia, and hypertension. Use of mail order pharmacy products,
gaps-in-caremeasures, and patient-requested, targetedmedication switches were
evaluated at the medication level. RESULTS: Across the classes of medications,
four of the five showed an increase in adherence following enrollment in CoachRx.
Among the customer subgroup sub-optimally adherent (MPR  80%) prior to en-
rolling in CoachRx, there was a statistically significant increase in adherence for all
five medication classes. Compliance to adherence related gaps-in-care increased
by 4% and the number of treatments filled solely through mail-order pharmacy
increased by 11% following enrollment. There was a 14.4% decrease in the share of
non-preferred brand medications, with no change in preferred brand medications
and a 2.2% increase in generic medications. Among the study participants, there
were 40 confirmed patient-requested switches from targetedmedications, with an
average ingredient cost savings of $661 per switch per year. CONCLUSIONS: The
main goal of CoachRx, to drive appropriate use of pharmacotherapy, was achieved
in the six-month, post-enrollment period. Improvement in care over such a short
period is a positive finding. These improvementsmay have an even greater impact
on futuremedical costs andmay lead to continued reductions inmedication costs.
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OBJECTIVES: The Centers for Medicare and Medicaid Services (CMS) has identified
several preventable adverse events, known as hospital-acquired conditions
(HACs), that in most cases CMS will not allow additional reimbursement to hospi-
tals. HACs are common or costly conditions that are acquired during the hospital
stay and could have been prevented through the application of evidence-based
guidelines. CMS has identified ten categories of HACs that are deemed to be pre-
ventable causes of morbidity and mortality. The objective of this study was to
document the prevalence of HACs for all-payers and to differentiate the impact of
HACs by payer and age group. METHODS: The study design was a retrospective
cohort from the 2008 Healthcare Cost andUtilization Project (HCUP) State Inpatient
Databases (SID) files. We used the CMS definition to identify HACs from the pres-
ent-on-admission (POA) indicator associated with secondary diagnoses in the SID.
The SID are the only multi-state all-payer data available that include the POA
indicator needed to identify HACs. We studied adult, non-maternal, medical-sur-
gical or selected surgical discharges, depending on the HAC, from community,
non-rehabilitation hospitals in fifteen states that reported POA indicators to HCUP.
RESULTS: Falls or trauma was the most prevalent HAC in our sample. For selected
surgical procedures, deep vein thrombosis/pulmonary embolism had the highest
rate of HACs (832 per 100,000 hip or knee replacement discharges). Medicaid dis-
charges had about twice the rate of manifestations of poor glycemic control and
more than twice the rate of selected surgical site infections relative to Medicare
discharges. For the conditions of stage III and IV pressure ulcers, falls and trauma,
catheter-associated urinary tract infection, and deep vein thrombosis/pulmonary
embolism the relative risk of acquiring a HAC increased with age. CONCLUSIONS:
The rate of HACs differed by payer and age group. Thus, it is important to consider
examining HACs by all third-party payers.
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OBJECTIVES:The objective of this researchwas to review the extent towhichHRQL
and other PROs have played a role in drug approval and labeling since the FDA
issued its draft guidance on the use of PRO measures and the EMA, its reflection
paper on HRQL in 2006. METHODS: This research was conducted through a sys-
tematic manual review of therapy area-specific regulatory guidelines (US and EU)
and product labelings issued during the period of January 1, 2006 to November 16,
2010. RESULTS: Fifteen and 34 guidance documents were released by the FDA and
the EMA respectively, containing recommendations for the inclusion of PRO end-
points in clinical trials. The FDA referred toHRQL (as a secondary endpoint) in three
of the 15 (20%) guidance. The EMA recommended use of HRQL endpoints in 22 of
the 34 (65%) guidance. The FDA approved 93 products with label claims that in-
cluded PRO endpoints (out of 432 total approvals). Of those, 8 products (8.6% of all
products with a PRO claim) documented treatment benefits characterized as HRQL.
The EMA approved 54 products that included PRO endpoints (out of 248 total ap-
provals), of which 16 products (29.62% of all products with a PRO claim) reflected
HRQL data. CONCLUSIONS: Our review showed that patients‘ perspective in clin-
ical research is important for the EMA and FDA, with HRQL endpoints still playing
a minor role. Our analysis suggests that EMA’s receptivity to HRQL endpoints is
greater than FDA’s,more sensitive to patient symptoms-based data. For the future,
we believe that patients’ involvement should be extended to get a more precise
idea of the PROs relevant to them. Other key players involved in reimbursement
and pricing decisions might have their say since financial health resources will
become scarce and that assessing value for money will be more crucial.
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OBJECTIVES: On March 23, 2010 the Patient Protection and Affordable Care Act
(PPACA) was signed into a law providing health insurance coverage for approxi-
mately 32million uninsuredAmericans. The objective is to determine the expected
changes in health care utilization for the uninsured after 2014when key provisions
of PPACA law become effective.METHODS:Medical Expenditure Panel Survey data
(2008) was used for the analysis. The differences in health care utilization between
the uninsured and those with private or Medicaid coverage was estimated using a
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